argenx SE | ARGX - Sales Revenues

Stock Price
647.20
Daily Change
1.40 0.22%
Monthly
0.43%
Yearly
20.57%
Q2 Forecast
630.50

argenx SE reported $1.12B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
UCB EUR 4.25B 764M Dec/2025